| Loss of ‘homeostatic’microglia and patterns of their activation in active multiple sclerosis T Zrzavy, S Hametner, I Wimmer, O Butovsky, HL Weiner, H Lassmann Brain 140 (7), 1900-1913, 2017 | 587 | 2017 |
| Iron and neurodegeneration in the multiple sclerosis brain S Hametner, I Wimmer, L Haider, S Pfeifenbring, W Brück, H Lassmann Annals of neurology 74 (6), 848-861, 2013 | 533 | 2013 |
| Disease-specific molecular events in cortical multiple sclerosis lesions MT Fischer, I Wimmer, R Höftberger, S Gerlach, L Haider, T Zrzavy, ... Brain 136 (6), 1799-1815, 2013 | 328 | 2013 |
| Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica T Misu, R Höftberger, K Fujihara, I Wimmer, Y Takai, S Nishiyama, ... Acta neuropathologica 125 (6), 815-827, 2013 | 246 | 2013 |
| PECAM-1 stabilizes blood-brain barrier integrity and favors paracellular T-cell diapedesis across the blood-brain barrier during neuroinflammation I Wimmer, S Tietz, H Nishihara, U Deutsch, F Sallusto, F Gosselet, R Lyck, ... Frontiers in immunology 10, 711, 2019 | 166 | 2019 |
| Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models C Schuh, I Wimmer, S Hametner, L Haider, AM Van Dam, RS Liblau, ... Acta neuropathologica 128 (2), 247-266, 2014 | 117 | 2014 |
| Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury T Zrzavy, C Schwaiger, I Wimmer, T Berger, J Bauer, O Butovsky, ... Brain 144 (1), 144-161, 2021 | 105 | 2021 |
| Pathogenic T cell responses against aquaporin 4 M Pohl, MT Fischer, S Mader, K Schanda, M Kitic, R Sharma, I Wimmer, ... Acta neuropathologica 122 (1), 21-34, 2011 | 104 | 2011 |
| Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples I Wimmer, AR Tröscher, F Brunner, SJ Rubino, CG Bien, HL Weiner, ... Scientific reports 8 (1), 1-17, 2018 | 93 | 2018 |
| Vaccination in multiple sclerosis: friend or foe? T Zrzavy, H Kollaritsch, PS Rommer, N Boxberger, M Loebermann, ... Frontiers in Immunology, 1883, 2019 | 88 | 2019 |
| Plasmalogens, platelet-activating factor and beyond–Ether lipids in signaling and neurodegeneration F Dorninger, S Forss-Petter, I Wimmer, J Berger Neurobiology of disease 145, 105061, 2020 | 87 | 2020 |
| Cell type-specific Nrf2 expression in multiple sclerosis lesions S Licht-Mayer, I Wimmer, S Traffehn, I Metz, W Brück, J Bauer, M Bradl, ... Acta neuropathologica 130 (2), 263-277, 2015 | 87 | 2015 |
| Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats M Kitic, S Hochmeister, I Wimmer, J Bauer, T Misu, S Mader, M Reindl, ... Acta neuropathologica communications 1 (1), 1-15, 2013 | 71 | 2013 |
| Neuroinflammatory responses in experimental and human stroke lesions I Wimmer, T Zrzavy, H Lassmann Journal of neuroimmunology 323, 10-18, 2018 | 65 | 2018 |
| Acute microglia ablation induces neurodegeneration in the somatosensory system SJ Rubino, L Mayo, I Wimmer, V Siedler, F Brunner, S Hametner, A Madi, ... Nature communications 9 (1), 1-13, 2018 | 64 | 2018 |
| Microglial nodules provide the environment for pathogenic T cells in human encephalitis AR Tröscher, I Wimmer, L Quemada-Garrido, U Köck, D Gessl, ... Acta neuropathologica 137 (4), 619-635, 2019 | 59 | 2019 |
| Neuropathological Variability within a Spectrum of NMDAR‐Encephalitis T Zrzavy, V Endmayr, J Bauer, S Macher, N Mossaheb, C Schwaiger, ... Annals of neurology 90 (5), 725-737, 2021 | 45 | 2021 |
| B cell depletion and SARS‐CoV‐2 vaccine responses in neuroimmunologic patients B Kornek, F Leutmezer, PS Rommer, M Koblischke, L Schneider, ... Annals of Neurology 91 (3), 342-352, 2022 | 34 | 2022 |
| Immunology of COVID‐19 and disease‐modifying therapies: the good, the bad and the unknown T Zrzavy, I Wimmer, PS Rommer, T Berger European Journal of Neurology 28 (10), 3503-3516, 2021 | 25 | 2021 |
| Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis A Steinmaurer, I Wimmer, T Berger, PS Rommer, J Sellner Current Pharmaceutical Design 28 (6), 437-444, 2022 | 22 | 2022 |
